Cargando…
SM-164 enhances the antitumor activity of adriamycin in human U2-OS cells via downregulation of X-linked inhibitor of apoptosis protein
The antitumor effects of SM-164 and adriamycin (ADM) on human osteosarcoma U2-OS cells, the underlying mechanism are yet to be investigated. In the present study, U2-OS cells were divided into control, ADM, SM-164, and ADM + SM-164 groups. In addition, cells treated with both SM-164 and ADM were fur...
Autores principales: | Chen, Jiangwei, Chen, Xuanyin, Chen, Xiaodong, Sun, Haiying, Yang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522877/ https://www.ncbi.nlm.nih.gov/pubmed/31059038 http://dx.doi.org/10.3892/mmr.2019.10181 |
Ejemplares similares
-
CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
por: Gao, Jian, et al.
Publicado: (2018) -
Effects of Methylxanthine Derivatives on Adriamycin Concentration and Antitumor Activity
por: Sadzuka, Yasuyuki, et al.
Publicado: (1995) -
Caffeine Modulates the Antitumor Activity and Toxic Side Effects of Adriamycin
por: Sadzuka, Yasuyuki, et al.
Publicado: (1993) -
CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma
por: Tu, Ming, et al.
Publicado: (2017) -
The IAP Antagonist SM-164 Eliminates Triple-Negative Breast Cancer Metastasis to Bone and Lung in Mice
por: Lei, Wei, et al.
Publicado: (2020)